Tesla
TSLA
NVIDIA
NVDA
Taiwan Semiconductor
TSM
Advanced Micro Devices
AMD
Qualcomm
QCOM
US Stock MarketDetailed Quotes
FOLD Amicus Therapeutics
- 9.520
- +0.210+2.26%
Trading Jan 3 14:21 ET
2.84BMarket Cap-28.00P/E (TTM)
9.520High9.270Low681.08KVolume9.300Open9.310Pre Close6.40MTurnover0.28%Turnover RatioLossP/E (Static)298.81MShares14.09052wk High15.92P/B2.34BFloat Cap9.02052wk Low--Dividend TTM245.30MShs Float25.390Historical High--Div YieldTTM2.69%Amplitude1.765Historical Low9.403Avg Price1Lot Size
About Amicus Therapeutics Company
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Company Profile
SymbolFOLD
Company NameAmicus Therapeutics
Listing DateMay 31, 2007
Issue Price15.00
Founded2002
CEOMr. Bradley L. Campbell
MarketNASDAQ
Employees517
Fiscal Year Ends12-31
Address47 Hulfish Street
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08542
Phone1-609-662-2000
Websitehttp://www.amicusrx.com
Company Executives
- Name
- Position
- Salary
- Bradley L. Campbell
- Director, President and Chief Executive Officer
- 8.20M
- Jeffrey P. Castelli, PhD
- Chief Development Officer
- 3.67M
- Samantha Prout
- Chief Accounting Officer and Controller
- --
- David M. Clark
- Chief People Officer
- 3.21M
- Simon Nicolas Reade Harford
- Chief Financial Officer
- 2.98M
- Ellen S. Rosenberg
- Chief Legal Officer, General Counsel and Corporate Secretary
- 4.08M
- Michael G. Raab
- Lead Independent Director and Chairman of the Board
- 426.25K
- Lynn Dorsey Bleil
- Independent Director
- 397.50K
- Burke W. Whitman
- Independent Director
- 391.25K
- Michael A. Kelly
- Independent Director
- 391.25K
- Margaret G. McGlynn
- Independent Director
- 401.25K
- Glenn P. Sblendorio
- Independent Director
- 407.07K
- Craig A. Wheeler
- Independent Director
- 398.50K
- Dr. Eiry W. Roberts, M.D.
- Independent Director
- 390.00K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.